24.915 USD
+0.09 (+0.38%)
Taking everything into account, PRVA scores 4 out of 10 in our fundamental rating. PRVA was compared to 100 industry peers in the Health Care Providers & Services industry. PRVA has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, PRVA is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
PRVA had positive earnings in the past year.
PRVA had a positive operating cash flow in the past year.
In multiple years PRVA reported negative net income over the last 5 years.
In the past 5 years PRVA always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 1.34%, PRVA perfoms like the industry average, outperforming 53.00% of the companies in the same industry.
With a Return On Equity value of 2.56%, PRVA perfoms like the industry average, outperforming 57.00% of the companies in the same industry.
With a Return On Invested Capital value of 2.45%, PRVA perfoms like the industry average, outperforming 48.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROIC | 2.45% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PRVA has a Profit Margin (0.89%) which is comparable to the rest of the industry.
PRVA's Profit Margin has declined in the last couple of years.
The Operating Margin of PRVA (1.38%) is comparable to the rest of the industry.
PRVA's Operating Margin has declined in the last couple of years.
PRVA has a worse Gross Margin (10.17%) than 75.00% of its industry peers.
In the last couple of years the Gross Margin of PRVA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% |
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRVA is destroying value.
Compared to 1 year ago, PRVA has more shares outstanding
The number of shares outstanding for PRVA has been increased compared to 5 years ago.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
PRVA has an Altman-Z score of 4.61. This indicates that PRVA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PRVA (4.61) is better than 82.00% of its industry peers.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.61 |
ROIC/WACC0.28
WACC8.77%
2.3 Liquidity
A Current Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
PRVA has a better Current ratio (1.67) than 63.00% of its industry peers.
PRVA has a Quick Ratio of 1.67. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
PRVA's Quick ratio of 1.67 is fine compared to the rest of the industry. PRVA outperforms 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
PRVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
PRVA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.43% yearly.
Looking at the last year, PRVA shows a quite strong growth in Revenue. The Revenue has grown by 19.01% in the last year.
Measured over the past years, PRVA shows a quite strong growth in Revenue. The Revenue has been growing by 17.17% on average per year.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
3.2 Future
The Earnings Per Share is expected to grow by 69.59% on average over the next years. This is a very strong growth
Based on estimates for the next years, PRVA will show a small growth in Revenue. The Revenue will grow by 2.73% on average per year.
EPS Next Y23.86%
EPS Next 2Y71.26%
EPS Next 3Y69.59%
EPS Next 5YN/A
Revenue Next Year19.33%
Revenue Next 2Y14.38%
Revenue Next 3Y13.26%
Revenue Next 5Y2.73%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 191.65, the valuation of PRVA can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as PRVA.
Compared to an average S&P500 Price/Earnings ratio of 26.76, PRVA is valued quite expensively.
Based on the Price/Forward Earnings ratio of 77.23, the valuation of PRVA can be described as expensive.
PRVA's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of PRVA to the average of the S&P500 Index (23.96), we can say PRVA is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 191.65 | ||
| Fwd PE | 77.23 |
4.2 Price Multiples
62.00% of the companies in the same industry are cheaper than PRVA, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as PRVA.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.68 | ||
| EV/EBITDA | 70.04 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRVA does not grow enough to justify the current Price/Earnings ratio.
PRVA's earnings are expected to grow with 69.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.03
PEG (5Y)25.78
EPS Next 2Y71.26%
EPS Next 3Y69.59%
5. Dividend
5.1 Amount
PRVA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:PRVA (12/12/2025, 3:40:05 PM)
24.915
+0.09 (+0.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.69%
Inst Owner Change2.16%
Ins Owners1.85%
Ins Owner Change0.2%
Market Cap3.06B
Revenue(TTM)2.04B
Net Income(TTM)18.17M
Analysts84.44
Price Target32.03 (28.56%)
Short Float %2.81%
Short Ratio3.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)2
Avg Revenue beat(2)11.82%
Min Revenue beat(2)5.73%
Max Revenue beat(2)17.91%
Revenue beat(4)4
Avg Revenue beat(4)8.08%
Min Revenue beat(4)0.75%
Max Revenue beat(4)17.91%
Revenue beat(8)8
Avg Revenue beat(8)5.39%
Revenue beat(12)10
Avg Revenue beat(12)0.33%
Revenue beat(16)10
Avg Revenue beat(16)-9.08%
PT rev (1m)-0.49%
PT rev (3m)3.29%
EPS NQ rev (1m)-37.27%
EPS NQ rev (3m)-40.31%
EPS NY rev (1m)-19.57%
EPS NY rev (3m)-17.44%
Revenue NQ rev (1m)2.3%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)3.28%
Revenue NY rev (3m)3.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 191.65 | ||
| Fwd PE | 77.23 | ||
| P/S | 1.5 | ||
| P/FCF | 27.68 | ||
| P/OCF | 27.68 | ||
| P/B | 4.32 | ||
| P/tB | 8.3 | ||
| EV/EBITDA | 70.04 |
EPS(TTM)0.13
EY0.52%
EPS(NY)0.32
Fwd EY1.29%
FCF(TTM)0.9
FCFY3.61%
OCF(TTM)0.9
OCFY3.61%
SpS16.61
BVpS5.77
TBVpS3
PEG (NY)8.03
PEG (5Y)25.78
Graham Number4.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROCE | 3.67% | ||
| ROIC | 2.45% | ||
| ROICexc | 5.77% | ||
| ROICexgc | N/A | ||
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% | ||
| FCFM | 5.42% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 112.37 | ||
| Cash Conversion | 296.89% | ||
| Profit Quality | 609.36% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.61 |
F-Score7
WACC8.77%
ROIC/WACC0.28
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
EPS Next Y23.86%
EPS Next 2Y71.26%
EPS Next 3Y69.59%
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
Revenue Next Year19.33%
Revenue Next 2Y14.38%
Revenue Next 3Y13.26%
Revenue Next 5Y2.73%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year573.2%
EBIT Next 3Y111.25%
EBIT Next 5Y64.24%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%
PRIVIA HEALTH GROUP INC / PRVA FAQ
What is the fundamental rating for PRVA stock?
ChartMill assigns a fundamental rating of 4 / 10 to PRVA.
What is the valuation status for PRVA stock?
ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.
Can you provide the profitability details for PRIVIA HEALTH GROUP INC?
PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.
What is the valuation of PRIVIA HEALTH GROUP INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 191.65 and the Price/Book (PB) ratio is 4.32.
What is the earnings growth outlook for PRIVIA HEALTH GROUP INC?
The Earnings per Share (EPS) of PRIVIA HEALTH GROUP INC (PRVA) is expected to grow by 23.86% in the next year.